Cerebrospinal fluid levels of biotin in various neurological disorders

Acta Neurologica Scandinavica

Volumn 99, Issue 6, 1999, Pages 387-392

  Anagnostouli, Maria ^b   Livaniou, E ^a   Nyalala, J O ^a   Evangelatos, G ^a   Zournas, C ^c   Ithakissios, D S ^a   Papageorgiou, C ^c  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NONE

Author keywords

Biotin; Cerebrospinal fluid; Neurological disorder; Serum

Indexed keywords

ANTICONVULSIVE AGENT; BIOTIN; BIOTINIDASE; IMMUNOGLOBULIN; VITAMIN BINDING PROTEIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DRUG COMPETITION; EPILEPSY; FEMALE; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; RADIOASSAY;

EID: 0033020599     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1999.tb07369.x     Document Type: Article

References (35)

1. 1. BONJOUR JP. Biotin in human nutrition. Ann NY Acad Sci 1985:97-103.
2. 2. SWEETMAN L, NYHAN W. Inheritable biotrin-treatable disorders and associated phenomena. Ann Rev Nutr 1986;6:317-43.
3. 3. BONJOUR JP. Biotin. In: MACHLIN LJ, ed. Handbook of Vitamins. New York: Marcel Dekker, Inc, 1984:336-403.
4. 4. SUCHY SF, SECOR MJ, WOLF B. Neurologic symptoms of biotinidase deficiency: Possible explanation. Neurology 1985;35:1510-11.
5. 5. PULSINELLI W, COOPER A. Metabolic encephalopathics and coma. In: SIEGEL G et al., eds. Basic Neurochemistry. New York: Raven Press, 1994:841-57.
6. 6. SIGEL H, MCCORMICK D, GRIESSER R et al. Metal ion complexes with biotin and biotin derivatives. Participation of sulfur in the orientation of divalent cations. Biochemistry 1969;8:2687-95.
7. 7. WOLF B. Disorders of biotin metabolism. In: SCRIVER CR, BEAUDET AL, SLY WS, VALLE D, eds. The metabolic and molecular bases of inherited disease, 7th edn. New York: McGraw-Hill Inc., 1995:3151-80.
8. 8. WOLF B, GRIER RE, SECOR MCVOY Jr et al. Biotinidase deficiency: a novel vitamin recycling defect. J Inherit Metab Dis 1985;8:53-8.
9. 9. BAUMGARTNER ER, SUORMALA T. Multiple carboxylase deficiency: Inherited and acquired disorders of biotin metabolism. Int J Vitam Nutr Res 1997;67:377-84.
10. 10. COWAN M, WARA DM, PACKMAN S et al. Multiple biotin-dependent carboxylase deficiencies associated with defects in T-cell and B-cell immunity. Lancet 1979;21:115-18.
11. 11. WOLF B. Worldwide survey of neonatal screening for biotinidase deficiency. J Inherit Metab Dis 1991;14:923-7.
12. 12. DURAN M, BAUMGARTNER ER, SUORMALA TM et al. Cerebrospinal fluid organic acids in biotinidase deficiency. J Inherit Metab Dis 1993;16:513-16.
13. 13. BAKER H, FRANK O, DEANGELIS B, FEINGOLD S. Vitamins in human blood and cerebrospinal fluid after intramuscular administration of several B-vitamins. Nutr Rep Int 1983;27:661-70.
14. 14. EVANGELATOS SA, KAKABAKOS SE, LIVANIOU E, EVANGELATOS GP, ITHAKISSIOS DS. Biotin radioligand assay with polyethylene glycol as separation reagent. Clin Chem 1991;37:1306-7.
15. 15. POSER C, PATY D, SCHEINBERG L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Neurology 1983;13:227-31.
16. 16. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases.
17. 17. MCKHANN G, DRACHMAN D, FOLSTEIN M, KATZMAN R, PRICE D, STADLAN EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
18. 18. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester groups. J Neurol Neurosurg Psychiatry 1994;57:416-18.
19. 19. ROMAN GC, TATEMICHI TK, ERKINJUNTTI T et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60.
20. 20. Commission on Classification and Terminology of the ILAE. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
21. 21. PENNOCK CA, PASSAUT LD, BOLTON FG. Estimation of cerebrospinal fluid protein. J Clin Pathol 1968;21:518-20.
22. 22. LIVANIOU E, EVANGELATOS GP, ITHAKISSIOS DS. Radioiodinated biotin derivatives for in vitro radioassays. J Nucl Med 1987;28:1430-4.
23. 12. Clin Chim Acta 1975;62:349.
24. 125I-labeled biotin derivative, avidin and avidin-double antibody reagents. Clin Chem 1987;33:1983-8.
25. 25. TOH H, KONDO H, TANABE T. Molecular evolution of biotin-dependent carboxylases. Eur J Biochem 1993;215:687-99.
26. 26. FRIGG M, HARTMANN D, STRAUB O-C. Biotin kinetics in cattle after intravenous and oral dosing. Int J Vit am Nutr Res 1994;64:36-40.
27. +-dependent biotin transport into brush-border membrane vesicles from human kidney cortex. Eur J Physiol 1993;422:499-505.
28. 28. KOUTSIKOS D, AGROYANNIS B, TZANATOS-EXARCHOU H. Biotin for diabetic peripheral neuropathy. Biomed Pharmacother 1990;44:511-14.
29. 29. BRAGUER D, GALLICE P, YATZIDIS H, BERLAND Y, CREVAT A. Restoration by biotin of the in vitro microtubule formation inhibited by uremic toxins. Nephron 1991;57:192-6.
30. 30. GUPTA JK, INGEGNO AP, COOK AW. Multiple sclerosis and malabsorption. Am J Gastroenterol 1977;68:560.
31. 31. NAGAMINE T, TAKEHARA K, FUKUI T, MORI M. Clinical evaluation of biotin-binding immunoglobulin in patients with Grave's disease. Clin Chim Acta 1994;226:47-54.
32. 32. TOURTELLOTE WW, BAUMHEFNER RW, SYNDULKO K et al. The long march of the cerebrospinal fluid profile indicative of clinical definite multiple sclerosis; and still marching. J Neuroimmunol 1988;20:217-27.
33. 33. KRAUSE KH, BONJOUR JP, BERLIT P, KOCHEN W. Biotin status of epileptics. Ann NY Acad Sci 1985;447:297-313.
34. 34. SEKIGUCHI T, NAGAMINE T. Inhibition of free radical generation by biotin. Biochem Pharmacol 1994;47:594-6.
35. 35. SMITH MA, PERRY G, RICHEY PL et al. Oxidative damage in Alzheimer's disease. Nature 1996;382:120-1.